Wasting Research - The Body

General Research

Research in Anti-Lipo Therapy Headlines AIDS Confab (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Moderate Weight Loss Increasingly Common for HIVers on HAART (September 1, 2005)
Wasting syndrome may be on the decline, but moderate weight loss -- of 5% or more -- has increased steadily since 1995, and appears unrelated to lipodystrophy.
From aidsmap.com
Rosiglitazone Linked to Benign Tumors in Man With Lipodystrophy (August 17, 2004)
A case report ties the use of rosiglitazone, an experimental treatment for lipodystrophy-related fat loss, to the development of lipomas in one HIV-infected person.
From aidsmap.com
Predicting Lipoatrophy After Treatment Initiation (February 9, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
In HIV Patients With Lipoatrophy, Antioxidants Lead to Only Modest Improvement in LDL Cholesterol (August 15, 2003)
From aidsmap.com
Current Research on the Mechanisms Causing Lipoatrophy and Potential Treatments (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
Rosiglitazone May Be Effective in Increasing Body Fat in Patients With Fat Wasting (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
Serostim Study Initiated (Spring 2001)
In CRIA Update, from AIDS Community Research Initiative of America
Thalidomide Pharmacokinetics, Safety and Effect on HIV Viral Load and Immune Parameters (February 6, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Hormones and Body Composition (July 12, 2000)
In The XIII International AIDS Conference, from The Body PRO
Exercise and HIV Wasting: From the Laboratory to the Clinic (July 2000)
In Body Positive, from Body Positive
The Use of Testosterone in AIDS Wasting Syndrome (May 3, 1999)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Anabolic Steroids, Exercise and Wasting (April 1999)
In GMHC Treatment Issues, from Gay Men's Health Crisis
The Effects of Oxandralone on Body Weight and Composition in Patients With HIV-Associated Weight Loss (July 2, 1998)
In The 12th International AIDS Conference, from The Body PRO
HIV-Related Clinical Updates: Wasting/Endocrine Disorders (May 2, 1998)
In The 8th Clinical Care Options for HIV Symposium, from The Body PRO
Diagnosis and Treatment of Endocrine Disorders in the HIV-Infected Patient (February 1998)
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
Anabolic Steroid Boosts Weight (September 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis